Chronic iron overload (in people with thalassaemia) - desferrioxamine, deferiprone and deferasirox: suspension of appraisal
Chronic iron overload (in people with thalassaemia) - desferrioxamine, deferiprone and deferasirox: final scope
Chronic iron overload (in people with thalassaemia) - desferrioxamine, deferiprone and deferasirox: final matrix
Chronic iron overload (in people with thalassaemia) - desferrioxamine, deferiprone and deferasirox: comments on draft scope
Chronic iron overload (in people with thalassaemia) - desferrioxamine, deferiprone and deferasirox: comments on the provisional matrix
Chronic iron overload (in people with thalassaemia) - desferrioxamine, deferiprone and deferasirox: provisional matrix - December 2010
Chronic iron overload (in people with thalassaemia) - desferrioxamine, deferiprone and deferasirox: draft scope for consultation - December 2010
Chronic iron overload - desferrioxamine, deferiprone and deferasirox: appendix B draft scope for consultation (pre-referral) - January 2010
Chronic iron overload - desferrioxamine, deferiprone and deferasirox: provisional matrix (pre-referral) - January 2010
Chronic iron overload - desferrioxamine, deferiprone and deferasirox: draft scope for consultation (pre-referral) - May 2010
Chronic iron overload - desferrioxamine, deferiprone and deferasirox: provisional matrix (pre-referral) - May 2010